Search research articles
Contact Us
Filters
Showing results (41-50 of 95) with videos related to
Page
of 10
Sort By:
World Journal of Urology
|
December 9, 2022
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
Michael Baboudjian, Guilhem Roubaud, Gaëlle Fromont, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
Emmanuel Chamorey, Marc Pujalte-Martin, Jean-Marc Ferrero, et al.
Therapeutic Advances in Medical Oncology
|
June 3, 2024
PARP inhibitors in prostate cancers, is it time for combinations?
Diego Teyssonneau, Charles Dariane, Eric Barret, et al.
Journal of Clinical Medicine
|
January 11, 2022
Overview of the Development and Use of Akt Inhibitors in Prostate Cancer
Anis Gasmi, Guilhem Roubaud, Charles Dariane, et al.
The French Journal of Urology
|
November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised disease
Guillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.
European Urology
|
February 7, 2022
Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [<sup>68</sup>Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography: Impact on Disease Management
Mathieu Gauthé, Paul Sargos, Nicolas Benziane Ouaritini, et al.
The French Journal of Urology
|
November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistance
Guillaume Ploussard, Charles Dariane, Romain Mathieu, et al.
Cancer Medicine
|
April 21, 2025
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients
Soufyan Annakib, Emma Di Méglio, Yona Dibert-Bekoy, et al.
European Urology
|
September 24, 2024
Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial
Dana E Rathkopf, Guilhem Roubaud, Kim N Chi, et al.
European Urology Open Science
|
May 31, 2022
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
Michael Baboudjian, Pawel Rajwa, Eric Barret, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 95) with videos related to
Sort By:
Page
of 10
World Journal of Urology
|
December 9, 2022
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
Michael Baboudjian, Guilhem Roubaud, Gaëlle Fromont, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
Emmanuel Chamorey, Marc Pujalte-Martin, Jean-Marc Ferrero, et al.
Therapeutic Advances in Medical Oncology
|
June 3, 2024
PARP inhibitors in prostate cancers, is it time for combinations?
Diego Teyssonneau, Charles Dariane, Eric Barret, et al.
Journal of Clinical Medicine
|
January 11, 2022
Overview of the Development and Use of Akt Inhibitors in Prostate Cancer
Anis Gasmi, Guilhem Roubaud, Charles Dariane, et al.
The French Journal of Urology
|
November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised disease
Guillaume Ploussard, Michaël Baboudjian, Eric Barret, et al.
European Urology
|
February 7, 2022
Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [<sup>68</sup>Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography: Impact on Disease Management
Mathieu Gauthé, Paul Sargos, Nicolas Benziane Ouaritini, et al.
The French Journal of Urology
|
November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistance
Guillaume Ploussard, Charles Dariane, Romain Mathieu, et al.
Cancer Medicine
|
April 21, 2025
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients
Soufyan Annakib, Emma Di Méglio, Yona Dibert-Bekoy, et al.
European Urology
|
September 24, 2024
Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial
Dana E Rathkopf, Guilhem Roubaud, Kim N Chi, et al.
European Urology Open Science
|
May 31, 2022
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
Michael Baboudjian, Pawel Rajwa, Eric Barret, et al.
Page
of 10